Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     Pharmaceuticals    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

Global Drug Delivery Formulations Market Research Report

  • Report Code: DR 1000
  • Publish Date: Upcoming
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount
Drug Delivery Formulations and its peer markets - Pharmaceutical Manufacturing Equipment, Contract Manufacturing Organizations, Next Generation Sequencing (NGS), Chromatography, Digital Pathology, Immunoassay, Contract Research Organization (CRO), Pharmaceutical Packaging Equipment, E-Clinical Trial Solutions and 8 other markets - adds up to total Pharmaceuticals market.

Drug Delivery Formulations can be segmented by Submarkets and Technologies. Submarkets of this market are Drug Delivery Technology. Technologies of this market are Oral Drug Delivery, Transmucosal Drug Delivery, Topical Drug Delivery, Nasal Drug Delivery and Ocular Drug Delivery.

 

Key Questions Answered

  • What are market estimates and forecasts; which of Drug Delivery Formulations markets are doing well and which are not?
  •  

    What makes our report unique?

    • This reports provides most granular segmentation on Drug Delivery Technology.
    • This report provides market sizing and forecast for the Drug Delivery Formulations market. It also provides market sizing and forecast along with the drivers/inhibitors/opportunity analysis for each of the micro markets.
    •  

      Audience for this report

      • Global Drug Delivery Formulations companies
      • Manufacturing Companies
      • Traders, distributors, and suppliers
      • Governmental and research organizations
      • Associations and industry bodies
      • Technology providers


1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Submarkets
4.1 Drug Delivery Technology
5 By Technologies
5.1 Oral Drug Delivery
5.2 Transmucosal Drug Delivery
5.3 Topical Drug Delivery
5.4 Nasal Drug Delivery
5.5 Ocular Drug Delivery

Please fill in the form below to receive a free copy of the Summary of this Report
















Global Drug Delivery Formulations Market Research Report

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE PUBLISHED
Global Oral Drug Delivery Market Global Oral Drug Delivery Market
The Global Oral Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies on in-house capabilities for the development of oral drug delivery technologies.The Market was Valued at $64.3 billion in 2013 and expected to be $100.8 billion by 2018, growing at a CAGR of 9.4%. The Oral Drug Delivery Market analyzes the market by segments such as Controlled Release, ODT and Taste Masking, Other Oral drug delivery technologies. The prominent players in the Market are Aptalis Pharmaceutical Technologies, Sky Pharma PLC, Tapemark, Baxter International Inc., Hovione Ltd.
Upcoming
Global Transmucosal Drug Delivery Market Global Transmucosal Drug Delivery Market
The Global Transmucosal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $2.91 billion in 2013 and expected to be $4.05 billion by 2018, growing at a CAGR of 6.8%. The Transmucosal Drug Delivery Market analyzes the market by segments such as Oral (Buccal and Sublingual), and others (Rectal, Vaginal).The prominent players in the Market BioDelivery Sciences International, Inc., Merck, NovaDel Pharma, Inc., Reckitt Benckiser Group plc., Cephalon and CIMA Labs.
Upcoming
Global Topical Drug Delivery Market Global Topical Drug Delivery Market
The Global Topical Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $9.44 billion in 2013 and expected to be $11.21 billion by 2018, growing at a CAGR of 3.5%. The Topical Drug Delivery Market analyzes the market by segments such as Semi-Solid Formulations, Liquid Formulations, and Solid Formulations.The prominent players in the Market are Galderma S.A., Stiefel Laboratories, Inc., Valeant Pharmaceuticals International, Inc.
Upcoming
Global Nasal Drug Delivery Devices Market Global Nasal Drug Delivery Devices Market
The Global Nasal Drug Delivery Devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $9.94 billion in 2013 and expected to be $15.02 billion by 2018, growing at a CAGR of 8.6%. The Nasal Drug Delivery Devices Market analyzes the market by segments such as Nasal Drops, Nasal Spray, Nasal Inhalers, Other Nasal Drug Delivery Technologies.The prominent players in the Market are 3M, Pfizer, Merck, GlaxoSmithKline (GSK), OptiNose AS, MedImmune, Kurve Technology, Inc.
Upcoming
Ocular Drug Delivery Ocular Drug Delivery
Ocular Drug Delivery and Oral Drug Delivery,
Upcoming
Controlled Release  Controlled Release 
Controlled Release  and Orodispersible Tablets (ODT) And Taste Masking  adds up to total
Upcoming
Orodispersible Tablets (ODT) And Taste Masking  Orodispersible Tablets (ODT) And Taste Masking 
Orodispersible Tablets (ODT) And Taste Masking  and Controlled Release  adds up to total
Upcoming
Eye Drops  Eye Drops 
Eye Drops  and Ointments And Gels  adds up to total Ocular...
Upcoming
Ointments And Gels  Ointments And Gels 
Ointments And Gels  and Eye Drops  adds up to total Ocular Drug...
Upcoming
Nasal Drops  Nasal Drops 
Submarkets of this market are Drug Delivery Technology.   Key Questions Answered What are market estimates and forecasts; which of Nasal Drops  markets are doing well and which are not?   What makes...
Upcoming
Semi-Solid Formulations  Semi-Solid Formulations 
Semi-Solid Formulations  and Liquid Formulations  and Solid...
Upcoming
Liquid Formulations  Liquid Formulations 
Liquid Formulations  and Semi-Solid Formulations  and
Upcoming
Solid Formulations  Solid Formulations 
Solid Formulations  and Semi-Solid Formulations  and
Upcoming
Oral (Buccal And Sublingual)  Oral (Buccal And Sublingual) 
Submarkets of this market are Drug Delivery Technology.   Key Questions Answered What are market estimates and forecasts; which of Oral (Buccal And Sublingual)  markets are doing well and which are not?   ...
Upcoming
North American Oral Drug Delivery Market North American Oral Drug Delivery Market
The North American Oral Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies on in-house capabilities for the development of oral drug delivery technologies.The Market was Valued at $29.0 billion in 2013 and expected to be $43.7 billion by 2018, growing at a CAGR of 8.6%. The Oral Drug Delivery Market analyzes the market by segments such as Controlled Release, ODT and Taste Masking, Other Oral drug delivery technologies. The prominent players in the Market are Aptalis Pharmaceutical Technologies, Sky Pharma PLC, Tapemark, Baxter International Inc., Hovione Ltd.
Upcoming
European Oral Drug Delivery Market European Oral Drug Delivery Market
The European Oral Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies on in-house capabilities for the development of oral drug delivery technologies.The Market was Valued at $16.9 billion in 2013 and expected to be $24.6 billion by 2018, growing at a CAGR of 7.7%. The Oral Drug Delivery Market analyzes the market by segments such as Controlled Release, ODT and Taste Masking, Other Oral drug delivery technologies. The prominent players in the Market are Aptalis Pharmaceutical Technologies, Sky Pharma PLC, Tapemark, Baxter International Inc., Hovione Ltd.
Upcoming
Asian Oral Drug Delivery Market Asian Oral Drug Delivery Market
The Asian Oral Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies on in-house capabilities for the development of oral drug delivery technologies.The Market was Valued at $10.9 billion in 2013 and expected to be $19.8 billion by 2018, growing at a CAGR of 12.7%. The Oral Drug Delivery Market analyzes the market by segments such as Controlled Release, ODT and Taste Masking, Other Oral drug delivery technologies. The prominent players in the Market are Aptalis Pharmaceutical Technologies, Sky Pharma PLC, Tapemark, Baxter International Inc., Hovione Ltd.
Upcoming
North American Nasal Drug Delivery Market North American Nasal Drug Delivery Market
The North American Nasal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $4.49 billion in 2013 and expected to be $6.62 billion by 2018, growing at a CAGR of 8.1%. The Nasal Drug Delivery Market analyzes the market by segments such as Nasal Drops, Nasal Spray, Nasal Inhalers, Other Nasal Drug Delivery Technologies.The prominent players in the Market are 3M, Pfizer, Merck, GlaxoSmithKline (GSK), OptiNose AS, MedImmune, Kurve Technology, Inc.
Upcoming
European Nasal Drug Delivery Market European Nasal Drug Delivery Market
The European Nasal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $2.95 billion in 2013 and expected to be $4.14 billion by 2018, growing at a CAGR of 7.0%. The Nasal Drug Delivery Market analyzes the market by segments such as Nasal Drops, Nasal Spray, Nasal Inhalers, Other Nasal Drug Delivery Technologies.The prominent players in the Market are 3M, Pfizer, Merck, GlaxoSmithKline (GSK), OptiNose AS, MedImmune, Kurve Technology, Inc.
Upcoming
Asian Nasal Drug Delivery Market Asian Nasal Drug Delivery Market
The Asian Nasal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $1.51 billion in 2013 and expected to be $2.69 billion by 2018, growing at a CAGR of 12.2%. The Nasal Drug Delivery Market analyzes the market by segments such as Nasal Drops, Nasal Spray, Nasal Inhalers, Other Nasal Drug Delivery Technologies.The prominent players in the Market are 3M, Pfizer, Merck, GlaxoSmithKline (GSK), OptiNose AS, MedImmune, Kurve Technology, Inc.
Upcoming
26 reports | Show
Connect With Us
US/CAN : +1-888-502-0539